Avant Technologies INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OQB
Avai Bio, Inc. (formerly Avant Technologies Inc.) filed its annual report on Form 10-K for the fiscal year ended March 31, 2026, detailing its AI technology focus, financial performance, and forward-looking strategies.
OQB
Avant Technologies Inc. reported a net loss of $1.14 million for fiscal year 2025, continuing its history of unprofitability and raising substantial doubt about its ability to continue as a going concern, despite strategic AI acquisitions and a planned pursuit of new financing.
OQB
Avant Technologies Inc. files an amendment to its annual report to correct unintentional errors in the Report of Independent Registered Public Accounting Firm.
OQB
Avant Technologies Inc. has filed an amendment to its annual report on Form 10-K to correct unintentional errors, including revisions to dates and updated officer certifications.
OQB
Avant Technologies Inc. reports its full year 2024 results, detailing strategic acquisitions in AI and IT consulting, alongside significant operating losses and a going concern warning.